Home
About NCCTG
About Clinical Trials
NCCTG Trial Listings
Treatment Trials
Prevention/ Symptom Management Trials
Treating Locations
NCCTG News
Links
Patient Advocacy
System
Institutional Members Only

Lung - Non-Small Cell

The following NCCTG cancer treatment clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
0617 A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients With Stage IIIA/B Non-Small Cell Lung Cancer
N0321 Phase I/II Study of PS-341 in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
N0528 A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
N0626 A Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-line Therapy in Patients With Advanced Non-Small Cell Lung Cancer

For more information, please discuss these trials with your physician, contact the NCCTG Operations Office or contact an NCCTG treating location near you.


Return to list of Cancer Treatment Trials



© Copyright 2008, NCCTG